Market Cap
Eli Lilly and Company
$586.39 Billion
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
AbbVie | $285.06 B |
Roche | $240.44 B |
Novartis | $220.27 B |
Company | Market Cap (USD) |
---|---|
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
AbbVie | $285.06 B |
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Eli Lilly and Company, more simply known as Eli Lilly or just Lilly, is a pharmaceutical company. Founded in 1876, Eli Lilly is engaged in the research, development, manufacturing, and marketing of insulin and endocrinology products for diabetes, psychiatric medication including Prozac, as well as treatments for osteoporosis, human growth hormone deficiency, pediatric growth conditions, autoimmune diseases, and diverse types of cancers.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.